AGP Executive Report
Last update: 8 hours agoDementia Care Breakthrough: A first-of-its-kind U.S. trial (LiBBY) found a medical THC+CBD formulation cut agitation in late-stage dementia patients—nearly 90% improved after 12 weeks, with far fewer still showing agitation versus placebo. Policy & Public Health: Texas Hemp Business Council pushed back hard on calls to treat hemp-derived THC as a major public health threat, arguing the data don’t support an alcohol/tobacco-level comparison. Clinical Cannabis Pipeline: Neurotech shares jumped after the FDA granted Investigational New Drug status for its medicinal cannabis program targeting childhood autism (phase III “Beyond Harmony”). Enforcement Watch: South Africa’s SANDF intercepted a parcel of suspected marijuana hidden in Doritos bound for a military quarantine area. Youth & School Context: New York’s “Cannabis Honestly” campaign rolls out resources for teens and trusted adults after educators reported cannabis use spilling into school life. Safety/Scam Alert: Jamaica’s regulator warned cultivators to verify licensing info and avoid permit rumors, fake messages, and investment scams.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
